In an effort to identify more efficacious, RES-based chemotherapeutics, we considered the effects of RES, BuRV, IsoRV, and PIV on cell viability, calcium signaling activity, p53, and pro-apoptotic markers in MDA-MB-231 breast cancer cells. Here, TP53 is linked to breast carcinoma.